Document Detail

Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adrenoceptor function in the rabbit.
MedLine Citation:
PMID:  3011616     Owner:  NLM     Status:  MEDLINE    
Defibrotide is a polydeoxyribonucleotide of mammalian origin which possesses profibrinolytic effect and PGI2-releasing capacity. Because of these properties, defibrotide has antithrombotic effects which are demonstrated in various experimental models of venous and arterial thrombosis. The present study indicates that defibrotide clearly protects against myocardial damage in the rabbit 3 days after total coronary artery occlusion. Furthermore, defibrotide prevents the decline of beta-adrenergic receptor function, a phenomenon related to excessive circulating catecholamines that occurs during the myocardial infarct. Defibrotide prevents the dramatic fall of creatine phosphokinase activity in the ischemic ventricle: metabolic changes which reflect changes in the cells affected by prolonged ischemia. Assumptions about the mode of action of defibrotide are given particularly in consideration of the interaction between the fibrinolytic activity and the PGI2-releasing capacity of this substance.
F Berti; G Rossoni; R Niada; C Omini; M Pretolani; C Mandelli
Related Documents :
25465516 - Tissue doppler imaging in echocardiography: value and limitations.
25459636 - Levosimendan: the current situation and new prospects.
25238036 - Nuclear assessment of right ventricle.
22758616 - The role of transesophageal echocardiography in the intraoperative period.
20970306 - Left atrial enlargement and phasic function in patients following non-st elevation myoc...
6854946 - Coarctation of the aorta in early infancy. left ventricular outflow tract obstruction a...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Haemostasis     Volume:  16 Suppl 1     ISSN:  0301-0147     ISO Abbreviation:  Haemostasis     Publication Date:  1986  
Date Detail:
Created Date:  1986-06-30     Completed Date:  1986-06-30     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  0371574     Medline TA:  Haemostasis     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  13-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Creatine Kinase / metabolism
Fibrinolytic Agents / pharmacology*
Histamine / pharmacology
Isoproterenol / antagonists & inhibitors
Myocardial Contraction / drug effects*
Myocardial Infarction / drug therapy*
Myocardium / enzymology
Polydeoxyribonucleotides / pharmacology*
Receptors, Adrenergic, beta / drug effects*
Receptors, Histamine / drug effects
Tyramine / antagonists & inhibitors
Reg. No./Substance:
0/Fibrinolytic Agents; 0/Polydeoxyribonucleotides; 0/Receptors, Adrenergic, beta; 0/Receptors, Histamine; 438HCF2X0M/defibrotide; 51-45-6/Histamine; 51-67-2/Tyramine; 7683-59-2/Isoproterenol; EC Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reactivation of cytomegalovirus in endometrial cells by estradiol.
Next Document:  In vivo effects of defibrotide on platelet c-AMP and blood prostanoid levels.